{"id": "1344439962498977793", "creation": 1609374440.0, "user_id": "1246083834766135298", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Results of #PfizerBioNTech #vaccine Phase 3 trial in over 43,000 volunteers over 16 years old, multi-country. \n\n95% efficacy against #COVID19 infection 1 week after 2nd dose. 52% efficacy between 1st-2nd doses.\n\n@NEJM \n\nhttps://t.co/kEal00RUZY https://t.co/fUnZxABtoW", "first_save": 1634559108.199414, "hashtags": ["#PFIZERBIONTECH", "#VACCINE", "#COVID19"]}